NCT07734298

Brief Summary

The goal of this observational study is to evaluate the diagnostic performance and concordance of bedside cervical ultrasonography compared to Fiberoptic Endoscopic Evaluation of Swallowing (FEES) for the early detection of post-extubation dysphagia in critically ill adult patients. The main questions it aims to answer are:

  • What is the degree of diagnostic concordance (Kappa index) between cervical ultrasonography and nasofibroscopy (FEES) for detecting dysphagia in the Intensive Care Unit (ICU)?
  • What are the sensitivity, specificity, and predictive values of ultrasonography as a non-invasive screening tool compared to the gold standard (FEES)?
  • Are there specific cut-off points for ultrasonographic parameters (such as hyoid bone displacement and laryngeal elevation) that accurately identify patients at risk of aspiration? Methodology and Comparison: Researchers will evaluate a cohort of patients who have undergone mechanical ventilation for more than 48 hours. The study compares the findings of cervical ultrasonography (an accessible and non-invasive bedside method) with FEES (the clinical gold standard) to determine the feasibility of ultrasound as an initial screening tool in the ICU setting. Participant Tasks: Participants will undergo the following procedures within 24 to 48 hours post-extubation: A bedside cervical ultrasonography to measure swallowing-related anatomical movements, such as hyoid displacement and laryngeal elevation. A nasofibroscopy (FEES) performed by trained personnel to directly visualize the pharyngeal and laryngeal structures during swallowing. A clinical evaluation of cranial nerve function and monitoring for respiratory complications like bronchoaspiration or pneumonia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Jul 2026Aug 2026

First Submitted

Initial submission to the registry

June 15, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 27, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 29, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Expected
Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

5 days

First QC Date

June 15, 2026

Last Update Submit

July 27, 2026

Conditions

Keywords

post-extubation dysphagiaCritical care ultrasonographySwallowing disorders

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Concordance (Kappa Index).

    The degree of diagnostic agreement between bedside cervical ultrasonography and Fiberoptic Endoscopic Evaluation of Swallowing (FEES) for the detection of post-extubation dysphagia. This will be evaluated using Cohen's Kappa coefficient to determine if ultrasonography is a reliable alternative to the gold standard.

    At 48 hours post-extubation.

Secondary Outcomes (3)

  • Diagnostic Sensitivity and Specificity.

    At 48 hours post-extubation.

  • Ultrasonographic Parameter Cut-off Points.

    At 48 hours post-extubation.

  • Incidence of Respiratory Complications.

    From ICU admission through ICU discharge, up to 30 days

Study Arms (1)

Diagnostic Evaluation Group

EXPERIMENTAL

This is a single-arm study where all participants who have been extubated after more than 48 hours of mechanical ventilation will undergo a sequential diagnostic assessment. Each participant will receive: * Cervical Ultrasonography: A non-invasive bedside evaluation to measure hyoid bone displacement and laryngeal elevation. * Fiberoptic Endoscopic Evaluation of Swallowing (FEES): The gold standard endoscopic procedure to visualize the pharyngeal and laryngeal phases of swallowing and detect penetration or aspiration.

Diagnostic Test: Bedside Cervical UltrasonographyDiagnostic Test: Fiberoptic Endoscopic Evaluation of Swallowing (FEES)

Interventions

Measurement of anatomical swallowing-related structures (hyoid bone and larynx) using a convex or linear transducer at the patient's bedside.

Diagnostic Evaluation Group

Endoscopic visualization of the larynx and pharynx during the administration of various bolus consistencies to assess swallowing safety.

Diagnostic Evaluation Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Critically ill patients admitted to the Intensive Care Unit (ICU).
  • Patients aged 18 years or older.
  • Patients who have required orotracheal intubation and mechanical ventilation for a period exceeding 48 hours.
  • Patients successfully liberated from mechanical ventilation (post-extubation phase).
  • Obtainment of signed Informed Consent from the patient or their legal representative.

You may not qualify if:

  • Patients with a known prior history of oropharyngeal dysphagia, esophageal disorders, or structural abnormalities of the upper airway.
  • Patients with pre-existing neurological diseases that compromise the swallowing reflex (e.g., advanced Parkinson's disease, previous stroke with residual dysphagia, Amyotrophic Lateral Sclerosis).
  • Patients with a history of head and neck surgery or radiotherapy.
  • Patients with a Glasgow Coma Scale (GCS) score \< 13 at the time of evaluation.
  • Patients with hemodynamic instability or severe respiratory distress that precludes the diagnostic procedures.
  • Anatomical limitations that prevent the correct placement of the ultrasound transducer or the introduction of the nasofibroscope (e.g., severe facial trauma, nasal obstruction).
  • Medical contraindication for Fiberoptic Endoscopic Evaluation of Swallowing (FEES).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital H+

Querétaro City, Querétaro, 7600, Mexico

RECRUITING

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 15, 2026

First Posted

July 29, 2026

Study Start

July 27, 2026

Primary Completion

August 1, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

July 29, 2026

Record last verified: 2026-07

Locations